The stock wants to run up much further. It took off for a while today and because of the shortened trading day and no new news it went back down. But the major trend is up, and the second batch of studies coming in on July 8th or 9th. The clinical trial will duplicate what the first one did and the stock should shoot up another 2 points or more. Remember ISIS owns this drug as of know and it looks like the only drug that can treat markedly elevated triglycerides. That alone, without any other indications could make this drug a big winner. If you short it I personally don't care because you will later on become a share buyer once the big move goes. t
jetman is exactly right on all points. this stock is on the launch pad, ready for blast off, and you don;'t want to be betting against it now of all times.
incidentally, jetman is a doctor, or should be. he's one of a number of brilliant posters you can read at IV. there you'll find actual discussions of isis, not just b.s. from dark and his many aliases.